Introduction {#sec1_1}
============

Topiramate is an oral sulfamate-substituted monosaccharide used in the treatment of epilepsy, migraine, and neuropathic pain \[[@B1]\]. Its use has been associated with secondary angle closure, which can mimic acute primary angle closure \[[@B1]\]. The suspicion for medication-induced angle closure is higher for bilateral presentation. This report presents a case of topiramate-induced bilateral secondary angle closure, with development and rapid progression of the cataract in one of the eyes, warranting surgical intervention.

Case Report {#sec1_2}
===========

An 18-year-old female had been diagnosed with bilateral acute angle closure at a different healthcare facility. She had been prescribed systemic antiglaucoma drugs and topical beta-blocker, pilocarpine, and prostaglandin analogue as treatment. The patient presented with complaints of pain, sudden diminution of vision, excessive watering, and photophobia (both eyes). In the course of history gathering, the patient reported the use of topiramate 25 mg twice a day for headache for 10 days. There was no history of trauma or symptoms suggestive of uveitis. The patient did not report use of any drug other than topiramate. She had a history of headache and there was no family history of glaucoma. Her visual acuity was right eye (OD) counting fingers 2 feet and left eye (OS) counting fingers 4 feet. The eyelids were swollen. Slit lamp examination revealed mild chemosis, ciliary flush, diffuse stromal haze (OD \> OS), microcystic corneal edema OS, and very shallow peripheral anterior chamber with areas of iridocorneal touch (OD \> OS). The pupil was semidilated and sluggishly reacting without rapid afferent pupillary defect. Intraocular pressure was OD 40 mm Hg and OS 32 mm Hg.

A presumptive diagnosis of topiramate-induced bilateral secondary acute angle closure attack was made. Topiramate use was stopped. Systemic and topical antiglaucoma drugs (intravenous mannitol 300 mL stat, acetazolamide 250 mg twice daily for a day, topical fixed drug combination of dorzolamide and timolol thrice daily, brimonidine 0.1% twice daily), topical cycloplegic (homatropine 1% twice daily), and a steroid (low-dose dexamethasone four times a day) were started.

On 1-day follow-up, the cornea had become clearer in both eyes (Fig. [1a, b](#F1){ref-type="fig"}) and the right eye showed peripheral anterior capsular lenticular opacity (Fig. [1a](#F1){ref-type="fig"}). There was no aqueous flair and the vitreous was clear. Fundus examination showed normal optic disc, retina, and macula. Intraocular pressure had decreased to OD 12 mm Hg and OS 10 mm Hg. Gonioscopy showed closed angles. Anterior segment optical coherence tomography (ASOCT) (Fig. [2a, b](#F2){ref-type="fig"}) showed forward movement of the iris-lens diaphragm with closed angles. B-scan of right eye (Fig. [3a](#F3){ref-type="fig"}) showed ciliochoroidal effusion, while B-scan of the left eye (Fig. [3b](#F3){ref-type="fig"}) was normal. At 1-week follow-up, ASOCT showed the iris-lens diaphragm to have moved back with open angle (Fig. [2c, d](#F2){ref-type="fig"}). One week after presentation, all antiglaucoma and cycloplegic drugs were stopped and the patient was continued on low-dose steroid for another week. At 2-month follow-up, the right eye showed formed anterior chamber and increased density of cataract, while the left eye did not show any lenticular changes (Fig. [1c, d](#F1){ref-type="fig"}). Thus, in right eye, there was a definite progression of cataract from 1 day to 2 months (Fig. [1e, f](#F1){ref-type="fig"}), and hence cataract surgery was advised.

Discussion {#sec1_3}
==========

Topiramate-induced bilateral angle closure glaucoma is well described \[[@B2], [@B3], [@B4], [@B5], [@B6]\]. Mahendradas et al. \[[@B7]\] recently showed topiramate-induced angle closure glaucoma with severe panuveitis, which resolved with systemic and topical steroids and cessation of topiramate. In this case, the cataract developed owing to severe uveitis. In the present case report, acute angle closure, forward movement of the iris-lens diaphragm, and iridocorneal touch (OD \> OS) resulted in glaukomflecken in the right eye as against left eye; previously published literature has also demonstrated glaukomflecken in acute angle closure \[[@B8]\]. Also, there were no signs of uveitis and still posterior subcapsular cataract developed unilaterally and progressed rapidly. Therefore, this case report suggests that in topiramate-induced bilateral secondary angle closure, there is a possibility of development and rapid progression of posterior subcapsular cataract warranting surgical intervention, and hence one must be vigilant in following up these cases.

However, there are some limitations to this study. Firstly, there was no objective measurement of anterior chamber depth to reveal any significant asymmetric chamber depth. Secondly, the investigations were not focused on all bilateral assessments at the first visit, and therefore retroillumination figures of this visit are not available. In our study, the formation of posterior subcapsular cataract after angle closure is at best presumptive and we cannot establish or deny the cause-effect relationship between topiramate-induced angle closure and progression of unilateral cataract with the current findings. The cataract formation in the right eye could be presumably explained by ciliochoroidal effusion, which was evident only in the right eye. Development of cataract in the presence of ciliochoroidal effusion has also been shown in earlier reports \[[@B9], [@B10]\].

To our knowledge, this is the first report of cataract development and rapid progression without any associated inflammation following topiramate-induced secondary angle closure in a young patient. Therefore, if angle closure presents, especially bilaterally, a detailed history and review of medications is mandatory, and these patients must be followed up on a regular basis so as to see any appearance and/or progression of cataract.
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![Slit lamp examination. **a, b** Slit lamp findings of the right (**a**) and left (**b**) eyes on 1-day follow-up. The right eye showed peripheral anterior capsular lenticular opacity, while in the left eye the lens was clear. **c, d** Slit lamp findings of the left eye at 2-month follow-up. **e, f** Slit lamp examination findings of the right eye on 1-day (**e**) and 2-month (**f**) follow-up. **e** Localized anterior capsular lenticular opacity in the right eye on 1-day follow-up which increased in density in due course of time. **f** At 2-month follow-up there was increased density of cataract. It is evident that at 2-month follow-up, the right eye showed formed anterior chamber. The left eye did not show any lenticular changes. Thus, in the right eye, there was definite progression of cataract from 1-day to 2-month follow-up.](cop-0011-0276-g01){#F1}

![ASOCT findings. **a, b** ASOCT findings of right (**a**) and left (**b**) eye at presentation. ASOCT showed forward movement of the iris-lens diaphragm and closed angles in both eyes. **c, d** ASOCT findings of the right (**c**) and left (**d**) eye at 1-week follow-up. At 1-week follow-up in both the eyes ASOCT showed the iris-lens diaphragm to have moved back and the angle was seen to be open. ASOCT, anterior segment optical coherence tomography.](cop-0011-0276-g02){#F2}

![B-scan findings. **a, b** B-scan findings of the right (**a**) and left (**b**) eye. B-scan of the right eye showed ciliochoroidal effusion while left eye B-scan was normal.](cop-0011-0276-g03){#F3}
